AveXis to build $55M gene therapy plant in Durham, North Carolina

AveXis, a Novartis company, is investing $55 million to build a new manufacturing facility in Durham, North Carolina, creating 200 jobs. The facility will produce gene therapy AVXS-101 for spinal muscular atrophy.

“AveXis, a Novartis company based in Illinois, is investing $55 million to build a new manufacturing facility in Durham, North Carolina.”biospace.com

• 2 sources
• biospace.comNovartis’ AveXis to Build Gene Therapy Factory in Durham, North Carolina - BioSpaceMark TerryMay 23, 2018
• smanewstoday.comAveXis, SMA Therapy Maker, Opening New Manufacturing Center in NCAna de Barros, PhDOct 25, 2018

Summarized from public sources; check the original articles before acting on it.